Chemed logo

Chemed

CHE | NYSE
Chart Builder DCF Calculator
$549.45
+$1.95 (+0.36%)
At close: Nov 16, 2026, 4:00 PM ET
$549.45
$0.00 (0.00%)
After-hours: Nov 16, 2026, 5:54 PM ET
+0.36%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
64.6
Fundamentals Strong
Market Sentiment Bullish
Moat Narrow
Sector Rank #93/1021 (Top 9%)

Key Statistics

Market Data

Market Cap $7.15B
1D Range
545.76 553.54
52W Range
368.59 553.54

Valuation (TTM)

PE 26.28
PB 8.30
EV/EBITDA 16.80

Valuation (NTM)

Forward PE 21.26
Forward PEG 1.60
Price Target $635.00
Loading financial charts...

Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers prim...

Sector Healthcare
Employees 15,811
IPO Date May 3, 1973
Fiscal Year January - December

Latest News

Chemtrade Logistics Income Fund (CHE.UN:CA) Q3 2026 Earnings Call Transcript

13 hours ago · seekingalpha.com

Chemtrade Logistics Income Fund (CHE.UN:CA) Q3 2026 Earnings Call Transcript
Here's Why Chemed (CHE) is a Strong Momentum Stock

6 days ago · zacks.com

Here's Why Chemed (CHE) is a Strong Momentum Stock
Chemed Corporation (CHE) Presents at 2026 UBS Global Healthcare Conference Transcript

8 days ago · seekingalpha.com

Chemed Corporation (CHE) Presents at 2026 UBS Global Healthcare Conference Transcript
Chemed Corporation Declares Quarterly Dividend of 70 Cents

11 days ago · globenewswire.com

Chemed Corporation Declares Quarterly Dividend of 70 Cents
Why Chemed (CHE) is a Top Value Stock for the Long-Term

15 days ago · zacks.com

Why Chemed (CHE) is a Top Value Stock for the Long-Term
Chemed Corporation to Present at the UBS 2026 Global Healthcare Conference

15 days ago · globenewswire.com

Chemed Corporation to Present at the UBS 2026 Global Healthcare Conference
What Chemed (CHE) Said on Its Q3 Earnings Call

19 days ago · marketbeat.com

What Chemed (CHE) Said on Its Q3 Earnings Call
Chemed Corporation (CHE) Q3 2026 Earnings Call Transcript

19 days ago · seekingalpha.com

Chemed Corporation (CHE) Q3 2026 Earnings Call Transcript
Chemed (CHE) Tops Q3 Earnings and Revenue Estimates

20 days ago · zacks.com

Chemed (CHE) Tops Q3 Earnings and Revenue Estimates
Chemed Reports Third-Quarter 2026 Results

20 days ago · globenewswire.com

Chemed Reports Third-Quarter 2026 Results

Earnings

Latest Earnings
Oct 27, 2026
EPS
$6.75
Beat +4.81%
REV
$690.94M
Beat +0.86%
Next Earnings
Feb 24, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
5
Consensus
Buy
Price Target
$635.00
Upside
+15.57%
Buy (3)
Hold (2)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.